178 related articles for article (PubMed ID: 12824887)
1. Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma.
Sung YK; Hwang SY; Park MK; Bae HI; Kim WH; Kim JC; Kim M
Cancer Sci; 2003 May; 94(5):421-4. PubMed ID: 12824887
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma.
Cao Y; Dave KB; Doan TP; Prescott SM
Cancer Res; 2001 Dec; 61(23):8429-34. PubMed ID: 11731423
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells.
Sung YK; Park MK; Hong SH; Hwang SY; Kwack MH; Kim JC; Kim MK
Exp Mol Med; 2007 Aug; 39(4):477-82. PubMed ID: 17934335
[TBL] [Abstract][Full Text] [Related]
4. Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: roles of cyclic AMP and p38 mitogen-activated protein kinase.
Liang YC; Wu CH; Chu JS; Wang CK; Hung LF; Wang YJ; Ho YS; Chang JG; Lin SY
World J Gastroenterol; 2005 May; 11(17):2557-63. PubMed ID: 15849811
[TBL] [Abstract][Full Text] [Related]
5. Expression of fatty acid-CoA ligase 4 during development and in brain.
Cao Y; Murphy KJ; McIntyre TM; Zimmerman GA; Prescott SM
FEBS Lett; 2000 Feb; 467(2-3):263-7. PubMed ID: 10675551
[TBL] [Abstract][Full Text] [Related]
6. The effect of fatty acid-CoA ligase 4 on the growth of hepatic cancer cells.
Hu C; Chen L; Jiang Y; Li Y; Wang S
Cancer Biol Ther; 2008 Jan; 7(1):131-4. PubMed ID: 18059177
[TBL] [Abstract][Full Text] [Related]
7. Intracellular unesterified arachidonic acid signals apoptosis.
Cao Y; Pearman AT; Zimmerman GA; McIntyre TM; Prescott SM
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11280-5. PubMed ID: 11005842
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.
Qiu W; David D; Zhou B; Chu PG; Zhang B; Wu M; Xiao J; Han T; Zhu Z; Wang T; Liu X; Lopez R; Frankel P; Jong A; Yen Y
Am J Pathol; 2003 Jun; 162(6):1961-74. PubMed ID: 12759252
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Acyl-CoA Ligase 4 (ACSL4) in Patients with Hepatocellular Carcinoma and its Prognosis.
Sun XJ; Xu GL
Med Sci Monit; 2017 Sep; 23():4343-4350. PubMed ID: 28887439
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of fatty acid-CoA ligase 4 in breast cancer.
Tsai CH; Sheen-Chen SM; Huang CY; Chen YJ; Chi SY; Ko SF; Lee YW; Liang JL; Hsu HW; Huang EY; Chen HC; Huang CC; Rau KM; Tang RP
Anticancer Res; 2014 Mar; 34(3):1239-43. PubMed ID: 24596366
[TBL] [Abstract][Full Text] [Related]
11. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation.
Meloni I; Muscettola M; Raynaud M; Longo I; Bruttini M; Moizard MP; Gomot M; Chelly J; des Portes V; Fryns JP; Ropers HH; Magi B; Bellan C; Volpi N; Yntema HG; Lewis SE; Schaffer JE; Renieri A
Nat Genet; 2002 Apr; 30(4):436-40. PubMed ID: 11889465
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma.
Morinaga S; Yamamoto Y; Noguchi Y; Imada T; Rino Y; Akaike M; Sugimasa Y; Takemiya S; Kameda Y; Takanashi Y
J Gastroenterol Hepatol; 2002 Oct; 17(10):1110-6. PubMed ID: 12201873
[TBL] [Abstract][Full Text] [Related]
14. A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene: proposal of a rapid enzymatic assay for screening mentally retarded patients.
Longo I; Frints SG; Fryns JP; Meloni I; Pescucci C; Ariani F; Borghgraef M; Raynaud M; Marynen P; Schwartz C; Renieri A; Froyen G
J Med Genet; 2003 Jan; 40(1):11-7. PubMed ID: 12525535
[TBL] [Abstract][Full Text] [Related]
15. High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma.
Fu M; Gu X; Ni H; Zhang W; Chang F; Gong L; Chen X; Li J; Qiu L; Shi C; Bao J
Int J Clin Exp Pathol; 2013; 6(11):2515-22. PubMed ID: 24228114
[TBL] [Abstract][Full Text] [Related]
16. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.
Hellerbrand C; Bataille F; Schlegel J; Hartmann A; Mühlbauer M; Schölmerich J; Büttner R; Hofstädter F; Bosserhoff AK
Liver Int; 2005 Apr; 25(2):357-66. PubMed ID: 15780062
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
Ndiaye H; Liu JY; Hall A; Minogue S; Morgan MY; Waugh MG
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32286604
[TBL] [Abstract][Full Text] [Related]
18. The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma.
Wu J; Du C; Lv Z; Ding C; Cheng J; Xie H; Zhou L; Zheng S
Dig Dis Sci; 2013 Dec; 58(12):3545-53. PubMed ID: 24077923
[TBL] [Abstract][Full Text] [Related]
19. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis.
Lu M; Nakamura RM; Dent ED; Zhang JY; Nielsen FC; Christiansen J; Chan EK; Tan EM
Am J Pathol; 2001 Sep; 159(3):945-53. PubMed ID: 11549587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
